Company Data
Tarsus Pharmaceuticals Inc.
Ticker
TARS
Current Price
$68.07 -4.11%
Market Cap
$3.4B
Price Target
Refer to Report
Volume
2.4M
52wk Range
$53.89 - $91.53
Overview
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company’s lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites.